COVID-19 Reinfections in Mexico City: Implications for public health response
de Anda-Jauregui, G.; Gomez-Romero, L.; Cedro-Tanda, A.; Canas, S.; Campos-Romero, A.; Alcantar-Fernandez, J.; Hidalgo-Miranda, A.; Herrera-Montalvo, L. A.
Show abstract
BackgroundSARS-CoV-2 pandemia continues to be important even when more than 60% of the global population has been vaccinated. As the pandemia evolves the number of reinfection cases will continue to increase as new variants are generated that evade the immune response. Understanding reinfections is important to guide the public health system and to inform decision-makers. MethodsWe downloaded clinical outcome and severity of infection data from the SISVER (respiratory disease epidemiological surveillance system) database. We sequenced SARS-CoV-2 samples, identified SARS-CoV-2 lineage and upload this genomic data to GISAID. We analyzed time and lineage between index infection and reinfection. We also analyzed the clinical outcome, severity of infection and vaccination status during reinfections. FindingsIn this study we confirmed that each wave of SARS-CoV-2 infections was characterized by a different viral variant showing a prevalence higher that 95%. We found that the fraction of reinfection is not linearly related to the average time of separation between waves with 40% of all the reinfections occurring at wave 5, the only wave with more than one SARS-CoV-2 variant with a prevalence higher than 80%. Regarding type of care 2.63% patients were considered ambulatory during the reinfection even when they were hospitalized during the index infection and only 0.78% presented the opposite behavior. Moreover, 6.74% reinfections transitioned from asymptomatic to mild or severe or from mild to severe; and 8.95% transitioned from severe to mild or asymptomatic or from mild to asymptomatic. The highest number of reinfections have occurred in unvaccinated patients (41.6%), followed shortly by vaccinated patients (31.9%). However, most reinfections occurred after wave 4 when the national vaccination efforts have reached 65% of the general population. InterpretationThe analyzed data suggests a diminished severity of infection during reinfection either if transitions in disease severity or transitions in type of patient care are considered. Finally, we also observed an overrepresentation of unvaccinated patients in reinfections.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020–April, 2021 95%
- Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA 95%
- The lower COVID-19 related mortality and incidence rates in Eastern European countries are associated with delayed start of community circulation 94%
Similar papers in this journal
- The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City 95%
- Turnover of SARS-CoV-2 lineages shaped the pandemic and enabled the emergence of new variants in the state of Rio de Janeiro, Brazil 94%
- Timeline of SARS-CoV2 spread in Italy: results from an independent serological retesting 94%
Similar papers in this journal
- Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Vaccinated and Unvaccinated Patients in Mexico City 96%
- Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals 94%
- Breakthrough Infections with SARS-CoV-2 in Vaccinated Students After a Festive Event – Identification of Risk Factors 94%
Similar papers in this journal
- Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients 95%
- Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India 94%
- Impact of Delta and Vaccination on SARS-CoV-2 transmission risk: Lessons for Emerging Breakthrough infections 94%
Similar papers in this journal
- Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave 94%
- Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India 93%
- Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.